论文部分内容阅读
作者报道1971～1979年经腰穿、CT、脑血管造影等检查确诊的228例动脉瘤性蛛网膜下腔出血(SAH),分别投用6-氨基己酸以防再出血,投卡那霉素和利血平以防脑血管痉挛。6-氨基已酸开始为24g/d 静注,连续5天后改为口服25g/d,至手术时为止。卡那霉素500mg,每日4次肌注。利血平每次0.2mg,每天3次,口服至术后1周。为估价术前用6-氨基己酸对预防再出血的有效性,对照组和治疗组的病人均选择:①发病后4天内住院;②入院时病情均属 Botterell 分级法的1～3级。对两组再出血率随访到病后第3周或至手术时
The authors report 228 cases of aneurysmal subarachnoid hemorrhage (SAH) diagnosed by lumbar puncture, CT, cerebral angiography and other tests from 1971 to 1979. They were administered 6-aminocaproic acid to prevent rebleeding, Su and reserpine to prevent cerebral vasospasm. 6-Aminohexanoic acid began to intravenous infusion of 24g / d, 5 days after continuous oral 25g / d, until the surgery date. Kanamycin 500mg, 4 times a day intramuscularly. Reserpine 0.2mg, 3 times a day, orally to 1 week after surgery. In order to evaluate the effectiveness of preoperative 6-aminocaproic acid in preventing rebleeding, patients in the control group and treatment group were selected: ① hospitalized within 4 days after onset; ② the patients were admitted to the hospital with grade 1 to 3 Botterell grading. The rate of rebleeding in the two groups was followed up to the third week after the illness or until the operation